ArticleTranslational cancer research2023

A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma.

Wei Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.